Literature DB >> 30883338

Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor.

Malgorzata A Krawczyk1,1, Gabrielle Karpinsky2,1, Ewa Izycka-Swieszewska3, Anna Gabrych4, Michal Kunc5, Aleksandra Fatyga4, Monika Garstka6, Malgorzata Styczewska6, Ewa M Sokolewicz6, Agnieszka Szlagatys-Sidorkiewicz7, Bernarda Kazanowska6, Ewa Bien1.   

Abstract

BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is rare, aggressive soft tissue sarcoma which may affect children.
OBJECTIVE: We aimed to assess prognostic significance of immunohistochemical (IHC) markers, osteopontin, fibronectin, survivin, cyclin D1 and p53, in pediatric MPNST.
METHODS: A total of 26 pediatric MPNST patients were enrolled in the current study with a median follow-up of 51 months. IHC staining using commercially available monoclonal antibodies were employed to detect analyzed antigens on tissue microarrays. Eventually, all markers were subclassified to high (H) and low (L) expression categories in all analyzed tumors.
RESULTS: High IHC expressions of survivin, cyclin D1, osteopontin, fibronectin, and p53 were detected in 18 (69.2%), 13 (50%), 16 (61.5%), 16 (61.5%), and 13 (50%) tumors, respectively. A significant correlation was demonstrated between cyclin D1 and osteopontin (p= 0.004). Both markers were associated with neurofibromatosis type 1 (NF1) status (p= 0.041 and p= 0.037, respectively). H-fibronectin was more prevalent in deeply located tumors (p= 0.046). None of the markers was associated with IRS stage, age at diagnosis, and tumor size. Univariate analysis identified IRS stage, regional lymph node metastases, NF1, and cyclin D1 as variables associated with overall survival (OS), whereas tumor depth, osteopontin, and cyclin D1 - for relapse-free survival (RFS). Subsequent multivariate analysis identified cyclin D1 and p53 as independent variables predicting RFS, whereas cyclin D1 and regional lymph nodes status were independent predictors for OS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30883338     DOI: 10.3233/CBM-181572

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  3 in total

1.  Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review.

Authors:  Enrico Martin; Ibtissam Acem; Dirk J Grünhagen; Judith V M G Bovée; Cornelis Verhoef
Journal:  Front Oncol       Date:  2020-12-22       Impact factor: 6.244

2.  High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor.

Authors:  Malgorzata A Krawczyk; Michal Kunc; Malgorzata Styczewska; Anna Gabrych; Gabrielle Karpinsky; Ewa Izycka-Swieszewska; Ewa Bien
Journal:  Diagnostics (Basel)       Date:  2021-03-26

Review 3.  Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.

Authors:  Jocelyn Y Hsu; Nathan D Seligson; John L Hays; Wayne O Miles; James L Chen
Journal:  JCO Precis Oncol       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.